Thymosinα1 stimulates cell proliferation by activating ERK1/2, JNK, and increasing cytokine secretion in human pancreatic cancer cells
- 1 April 2007
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 248 (1) , 58-67
- https://doi.org/10.1016/j.canlet.2006.05.019
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Roles of Thymosins in Cancers and Other Organ SystemsWorld Journal of Surgery, 2005
- Thymalfasin: an immune system enhancer for the treatment of liver diseaseJournal of Gastroenterology and Hepatology, 2004
- Thymalfasin (thymosin‐alpha 1) therapy in patients with chronic hepatitis BJournal of Gastroenterology and Hepatology, 2004
- Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis CReviews in Medical Virology, 2003
- Immunodeficiency and cancer: prospects for correctionInternational Immunopharmacology, 2003
- Prothymosin α Is Processed to Thymosin α1 and Thymosin α11 by a Lysosomal Asparaginyl EndopeptidaseJournal of Biological Chemistry, 2003
- Regulation of prothymosin α by estrogen receptor α: molecular mechanisms and relevance in estrogen-mediated breast cell growthOncogene, 2002
- Expression of the Prothymosin-α Gene as a Prognostic Factor in Lung CancerSurgery Today, 2001
- Thymosin alpha 1 in the treatment of cancer: from basic research to clinical applicationInternational Journal of Immunopharmacology, 2000
- Fifteen years of prothymosin alpha: contradictory past and new horizonsPeptides, 2000